Transgene Immunogenicity
Transgene Immunogenicity is the propensity of a transgene-encoded protein to elicit an adaptive immune response against its expressed product following gene therapy, distinguished from other sources of immunogenicity by its origin in exogenously delivered genetic material rather than host antigens or vector components.
40
Publications
3.6K
Citations
293
Authors
105
Institutions
Publications per year
2017–2026
12
40
Murine Leukemia Induced by Retroviral Gene Marking
Zhixiong Li, J. Düllmann, Bernd Schiedlmeier et al. · Science · 2002 · 654 citations
Manal Morsy, Mingcheng Gu, Sherri L. Motzel et al. · Proceedings of the National Academy of Sciences · 1998 · 370 citations
1–5 of 40
293
2
h-index
2
h-index
2
h-index
2
h-index
1
h-index
1–5 of 293
105
University of Pennsylvania
Philadelphia, United States
5 h-index
18 publications
2.7K citations

University of Maryland, Baltimore
Baltimore, United States
2 h-index
6 publications
2.4K citations
University of Massachusetts Chan Medical School
Worcester, United States
2 h-index
17 publications
759 citations

Sorbonne Université
Paris, France
2 h-index
9 publications
471 citations

Children's Hospital of Philadelphia
Philadelphia, United States
2 h-index
15 publications
2.7K citations

Centre National de la Recherche Scientifique
Paris, France
2 h-index
13 publications
241 citations

Hokkaido University
Sapporo, Japan
2 h-index
10 publications
270 citations
Inserm
Paris, France
2 h-index
17 publications
647 citations
1–8 of 105
4 publications · 170 citations
4
h-index
3 publications · 265 citations
3
h-index
3 publications · 157 citations
3
h-index
2 publications · 109 citations
2
h-index
Repository · 2 publications · 78 citations
2
h-index
1–5